Modeling drug resistance in a conjoint normal-tumor setting.

about

MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance.Modeling multi-mutation and drug resistance: analysis of some case studies.

P2860

Q41126784-16E4921B-FFA9-4611-AD99-247AAAD5CC17 Q42314760-9BC05259-6E19-476F-8F54-E356285BB400

P2860

Modeling drug resistance in a conjoint normal-tumor setting.

Item

http://www.wikidata.org/entity/Q40599449

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Modeling drug resistance in a conjoint normal-tumor setting.

@en

type

Item

label

Modeling drug resistance in a conjoint normal-tumor setting.

@en

prefLabel

Modeling drug resistance in a conjoint normal-tumor setting.

@en

P1476

Modeling drug resistance in a conjoint normal-tumor setting.

@en

P2093

Mitra Shojania Feizabadi

http://www.w3.org/2001/XMLSchema#string

Tarynn M Witten

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer.

Current advances in mathematical modeling of anti-cancer drug penetration into tumor tissues

Mechanisms of cancer drug resistance

Cancer drug resistance: an evolving paradigm

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium.

The growth law of primary breast cancer as inferred from mammography screening trials data.

Evolution of acquired resistance to anti-cancer therapy.

The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease.

Chemotherapy in conjoint aging-tumor systems: some simple models for addressing coupled aging-cancer dynamics

P2888

1742-4682-12-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-4682-12-3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270965833

http://www.w3.org/2001/XMLSchema#string

P6179

1044399552

http://www.w3.org/2001/XMLSchema#string

P698

25588472

http://www.w3.org/2001/XMLSchema#string

P932

4429337

http://www.w3.org/2001/XMLSchema#string

Modeling drug resistance in a conjoint normal-tumor setting.

about

P2860

P2860

Modeling drug resistance in a conjoint normal-tumor setting.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932